| CFLGX | VIVIX | CFLGX / VIVIX | |
| Total Expense Ratio | 1.41 | 0.04 | 3,525% |
| Annual Report Gross Expense Ratio | 1.41 | 0.04 | 3,525% |
| Fund Existence | 35 years | 28 years | - |
| Gain YTD | 2.940 | 13.976 | 21% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 5000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 356M | 216B | 0% |
| Annual Yield % from dividends | 3.06 | 2.05 | 149% |
| Returns for 1 year | 1.51 | 12.39 | 12% |
| Returns for 3 years | 47.14 | 37.40 | 126% |
| Returns for 5 years | 66.68 | 64.94 | 103% |
| Returns for 10 years | 123.41 | 133.37 | 93% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| DPREX | 13.80 | 0.02 | +0.15% |
| Nomura Global Listed Real Assets A | |||
| VWNAX | 84.23 | 0.11 | +0.13% |
| Vanguard Windsor II Admiral | |||
| BAFGX | 9.59 | 0.01 | +0.10% |
| Brown Advisory Growth Equity Inst | |||
| ESPIX | 36.92 | 0.03 | +0.08% |
| Allspring Special Small Cap Value Adm | |||
| BOSOX | 17.04 | N/A | N/A |
| Boston Trust Walden Small Cap | |||